Burns Open (Jul 2024)

Clinical evaluation of the efficiency and safety of the Tromboguard® hemostatic dressing for donor sites of split-thickness skin graft: A multicenter study

  • Jerzy Strużyna,
  • Tomasz Korzeniowski,
  • Michał Tobiasz,
  • Agnieszka Surowiecka,
  • Joanna Piszczek,
  • Andrzej Krajewski,
  • Maciej Mazurek,
  • Elżbieta Młyńska-Krajewska,
  • Ireneusz Pudło,
  • Adrian Litewka,
  • Jarosław Olszyna,
  • Sławomir Zacha,
  • Paulina Paul,
  • Karolina Turlakiewicz,
  • Witold Sujka

Journal volume & issue
Vol. 8, no. 3
pp. 197 – 203

Abstract

Read online

Worldwide, burns are the fourth most frequent type of injury. The treatment of burn wounds requires a lot of experience and an interdisciplinary approach including both surgical treatment and pharmacological wound care. The most common management of burn wounds is debridement and wound closure through the use of skin grafts. The purpose of the study was to evaluate the hemostatic and antibacterial effects of the commercially available Tromboguard® foam dressing with an active layer containing alginates and chitosan. The site of application of the product was the donor fields for skin grafts. Findings proved that a polyurethane foam dressing with an active chitosan-alginate layer is a useful option for achieving rapid hemostasis, antimicrobial protection and effective healing at split-thickness skin graft donor sites. Substances present in the active layer promote clot formation and the wound healing process.

Keywords